| Phosphate binder use, last 3 months |
| Total N | N | Weighted % | ||
|---|---|---|---|---|
| National sample | Month | |||
| Overall | MAY15 | 10,058 | 8,126 | 86.1% |
| JUN15 | 10,530 | 8,505 | 85.7% | |
| JUL15 | 10,928 | 8,800 | 85.5% | |
| AUG15 | 10,887 | 8,735 | 84.8% | |
| SEP15 | 11,109 | 8,912 | 84.8% | |
| OCT15 | 11,187 | 8,974 | 84.9% | |
| NOV15 | 11,194 | 8,983 | 85.3% | |
| DEC15 | 11,086 | 8,866 | 84.6% | |
| JAN16 | 11,229 | 9,016 | 85.4% | |
| FEB16 | 11,245 | 9,057 | 85.2% | |
| MAR16 | 11,298 | 9,089 | 84.8% | |
| APR16 | 11,102 | 8,949 | 84.9% | |
| MAY16 | 11,419 | 9,257 | 85.1% | |
| JUN16 | 11,389 | 9,268 | 85.4% | |
| JUL16 | 11,217 | 9,131 | 85.9% | |
| AUG16 | 10,977 | 9,010 | 86.5% | |
| SEP16 | 11,021 | 9,065 | 86.0% | |
| OCT16 | 10,908 | 8,992 | 86.3% | |
| NOV16 | 10,811 | 8,896 | 86.1% | |
| DEC16 | 10,577 | 8,722 | 86.5% | |
| JAN17 | 10,798 | 8,928 | 86.4% | |
| FEB17 | 10,710 | 8,830 | 86.0% | |
| MAR17 | 10,650 | 8,752 | 86.8% | |
| APR17 | 10,516 | 8,668 | 87.0% | |
| MAY17 | 10,782 | 8,929 | 86.8% | |
| JUN17 | 10,781 | 8,930 | 86.4% | |
| JUL17 | 10,694 | 8,749 | 85.6% | |
| AUG17 | 10,467 | 8,580 | 86.1% | |
| SEP17 | 10,659 | 8,817 | 86.6% | |
| OCT17 | 10,614 | 8,774 | 85.7% | |
| NOV17 | 10,587 | 8,735 | 86.2% | |
| DEC17 | 10,410 | 8,584 | 86.7% | |
| JAN18 | 10,635 | 8,707 | 86.4% | |
| FEB18 | 10,650 | 8,741 | 87.1% | |
| MAR18 | 9,365 | 7,585 | 82.6% | |
| APR18 | 6,289 | 5,026 | 78.0% | |
| MAY18 | 10,305 | 8,135 | 79.5% | |
| JUN18 | 10,724 | 8,429 | 79.8% | |
| JUL18 | 11,124 | 8,719 | 79.6% | |
| AUG18 | 11,522 | 9,018 | 79.6% | |
| SEP18 | 11,908 | 9,310 | 79.7% | |
| OCT18 | 11,879 | 9,280 | 79.5% | |
| NOV18 | 11,858 | 9,299 | 79.7% | |
| DEC18 | 11,707 | 9,241 | 79.8% | |
| JAN19 | 11,615 | 9,223 | 80.6% | |
| FEB19 | 11,571 | 9,148 | 80.5% | |
| MAR19 | 11,631 | 9,227 | 80.7% | |
| APR19 | 11,478 | 9,180 | 81.2% | |
| MAY19 | 11,587 | 9,325 | 81.7% | |
| JUN19 | 11,912 | 9,564 | 81.7% | |
| JUL19 | 12,376 | 9,860 | 81.1% | |
| AUG19 | 12,440 | 9,921 | 80.2% | |
| SEP19 | 12,368 | 9,911 | 79.7% | |
| OCT19 | 11,977 | 9,672 | 79.7% | |
| NOV19 | 12,493 | 10,046 | 79.0% | |
| DEC19 | 12,351 | 9,973 | 79.3% | |
| JAN20 | 12,285 | 9,912 | 79.0% | |
| FEB20 | 12,212 | 9,875 | 79.3% | |
| MAR20 | 12,082 | 9,826 | 79.5% | |
| APR20 | 11,714 | 9,626 | 79.9% | |
| MAY20 | 12,034 | 9,911 | 80.3% | |
| JUN20 | 11,914 | 9,786 | 80.0% | |
| JUL20 | 11,922 | 9,837 | 80.5% | |
| AUG20 | 11,852 | 9,778 | 80.2% | |
| SEP20 | 11,682 | 9,656 | 80.9% | |
| OCT20 | 11,366 | 9,436 | 81.0% | |
| NOV20 | 11,550 | 9,573 | 80.9% | |
| DEC20 | 11,383 | 9,402 | 80.6% | |
| JAN21 | 11,356 | 9,403 | 80.5% | |
| FEB21 | 10,377 | 8,566 | 81.5% | |
| Values for each month reflect any prescription during prior three months |
| Facility sample transitioned from DOPPS 4 to 5 in Jan-Apr 2012 (see "Study Sample and Methods"). |
| Facility sample transitioned from DOPPS 5 to 6 in Mar-Jul 2015 (see "Study Sample and Methods"). |
| Facility sample transitioned from DOPPS 6 to 7 in Feb-May 2018 (see "Study Sample and Methods"). |
| Source: US-DOPPS Practice Monitor, May 2021; http://www.dopps.org/DPM |